Clinical Trials
13
Active:0
Completed:9
Trial Phases
3 Phases
Phase 1:5
Phase 2:3
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (38.5%)Phase 1
5 (38.5%)Phase 2
3 (23.1%)A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients
Phase 2
Not yet recruiting
- Conditions
- Knee Osteoarthritis (Knee OA)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-25
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Glaceum
- Target Recruit Count
- 60
- Registration Number
- NCT06845553
A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Glaceum
- Target Recruit Count
- 90
- Registration Number
- NCT06329141
- Locations
- 🇰🇷
Hallym University Medical Center, Anyang, Gyeonggi, Korea, Republic of
🇰🇷The Catholic University of Korea Uijeongbu St.Marys Hostpial, Uijeongbu, Gyeonggi, Korea, Republic of
🇰🇷Inje University Busan Paik Hospital, Busan, Korea, Republic of
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Glaceum
- Target Recruit Count
- 40
- Registration Number
- NCT05642377
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Glaceum
- Target Recruit Count
- 36
- Registration Number
- NCT05310032
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Glaceum
- Target Recruit Count
- 81
- Registration Number
- NCT05197556
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- Next
News
No news found